PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
27-Nov-2024 Marinomed Biotech AG signs agreement for sale of Carragelose business to French Unither Pharmaceuticals Marinomed Biotech AG
26-Nov-2024 Marinomed Biotech AG signs agreement for sale of Carragelose business to French Unither Pharmaceuticals Marinomed Biotech AG
26-Nov-2024 Immunic, Inc. to Participate in Investor Conference in December Immunic AG
26-Nov-2024 Viromed Medical AG: cold plasma as a digital antibiotic for the lungs Viromed Medical AG
25-Nov-2024 SYNBIOTIC integrates greensby: Universal platform for the entire hemp and cannabis industry SYNBIOTIC SE
22-Nov-2024 Comment on withdrawn non-binding offer Evotec SE
22-Nov-2024 Eckert & Ziegler raises its forecast for the current financial year once again Eckert & Ziegler SE
22-Nov-2024 Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission Drägerwerk AG & Co. KGaA
22-Nov-2024 HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan HUTCHMED
22-Nov-2024 Vita 34 continues to show increasing revenue, improved profitability and stronger cash generation in the third quarter of 2024 Vita 34 AG
22-Nov-2024 Modern Dental Group Acquired the Top 1 Dental Laboratory in Thailand Solidified its Leading Position in the Global Market Modern Dental Group Limited
21-Nov-2024 Elemental Machines Launches New Product to Enhance Clean Room Alerting and Monitoring Elemental Machines
21-Nov-2024 Vetter strengthens senior management team for further sustainable growth Vetter
21-Nov-2024 APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived APONTIS PHARMA AG
21-Nov-2024 Vicebio Advances Clinical Study of RSV/hMPV Bivalent Vaccine & Strengthens Board with Appointments of World Class Veterans Vicebio
21-Nov-2024 First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach Pentixapharm Holding AG
21-Nov-2024 EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%. MPH Health Care AG
21-Nov-2024 Xlife Sciences AG Announces the listing of FUSE-AI GmbH on the London Stock Exchange in the First Half of 2025 Xlife Sciences AG
20-Nov-2024 Model N Introduces GenAI and Intelligent Data Innovations to Market-Leading Revenue Optimization and Compliance Offering Model N
20-Nov-2024 Retinal Scanning Startup DeepEyeVision, Inc. is First in the World to Receive Validation from BSI's New AI Algorithm Audit and Dataset Testing Services DeepEyeVision